The data showed that MVD in the tumor stroma was significantly higher in patients with elevated IL-33 expression, suggesting that the IL-33/ST2 axis can promote malignancy and tumor aggressiveness by remodeling the TME [111]. The gene discussed is IL1RL1; the disease is neoplasm.